procaterol has been researched along with Obesity in 1 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Basal lipolysis, maximal lipolytic responses to isoprenaline (beta-AR agonist), dobutamine and procaterol (beta1- and beta2-AR agonists, respectively) as well as maximal antilipolytic effects of epinephrine or UK-14304 (alpha2-AR agonist) were similar before and after weight reduction." | 3.70 | Regional and gender variations in adipose tissue lipolysis in response to weight loss. ( Alméras, N; Després, JP; Imbeault, P; Lacaille, M; Langin, D; Mauriège, P; Tremblay, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mauriège, P | 1 |
| Imbeault, P | 1 |
| Langin, D | 1 |
| Lacaille, M | 1 |
| Alméras, N | 1 |
| Tremblay, A | 1 |
| Després, JP | 1 |
1 other study available for procaterol and Obesity
| Article | Year |
|---|---|
Regional and gender variations in adipose tissue lipolysis in response to weight loss.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Dob | 1999 |